Skip to main content
Funded Studies

Glenn T. Stebbins, PhD

Professor at Rush University Medical Center

Location: Chicago, IL United States

Glenn Stebbins, PhD, is a professor in the department of neurological sciences at Rush University Medical Center. He has extensive experience with rating-scale testing and development, having participated in the development of the Unified Dyskinesia Rating Scale (UDysRS), serving on the steering committee of the Movement Disorder Society revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and taking part in the current Common Data Elements recommended assessment for Parkinson’s disease (PD). He is actively involved in the development of validated, non-English translations of rating scales including the UDysRS and MDS-UPDRS. Dr. Stebbins currently serves as co-director for the International Parkinson and Movement Disorder Society Clinical Outcome Assessment Program and as consultant and chief statistician for numerous clinical studies in PD and other movement disorders.


Associated Grants

  • Evaluating Patient-reported Outcome Assessment in Early Parkinson’s Disease

    2021


  • Unified Dyskinesia Rating Scale: Application for FDA Designation as a Preferred Scale for Assessing Dyskinesia in Parkinson’s Disease

    2015


  • Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

    2012


  • Validation of Dyskinesia Rating Scales

    2009


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.